A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19
Nima Ghasemzadeh1, Nathan Kim2, Shy Amlani3
1Georgia Heart Institute, Gainesville, GA 30501, USA.
Insights
Coronavirus disease 2019 (COVID-19) increases risks for ST-elevation myocardial infarction (STEMI) patients. COVID-19 patients with STEMI face higher morbidity and mortality compared to those without the virus.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic has significantly increased global morbidity and mortality.
- Patients with COVID-19 are susceptible to cardiovascular complications, including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis.
Purpose of the Study:
- To review current knowledge on ST-elevation myocardial infarction (STEMI) in COVID-19 patients.
- To examine the pathophysiology, clinical presentation, and outcomes of STEMI in the context of COVID-19.
- To assess the pandemic's impact on STEMI care.
Main Methods:
- Literature review of current knowledge.
- Analysis of pathophysiology, clinical presentation, and outcomes.
- Evaluation of the effect of the COVID-19 pandemic on STEMI care.
Main Results:
- Patients with COVID-19 who develop STEMI exhibit higher risks of morbidity and mortality.
- Comparison with age- and sex-matched STEMI patients without COVID-19 highlights increased risk.
- The pandemic has influenced the overall management and care of STEMI patients.
Conclusions:
- COVID-19 presents a significant risk factor for adverse outcomes in STEMI patients.
- Understanding the interplay between COVID-19 and STEMI is crucial for patient management.
- The pandemic necessitates adaptations in STEMI care protocols to mitigate risks.
Abstract:
The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
